A Los Angeles jury ordered Johnson &amp; Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause cancer.
The family of Mae Moore, a California resident who died at age 88 in 2021, sued the company the same year, claiming J&amp;J&#8217;s talc baby powder products contained asbestos fibers that caused her rare cancer. The jury late on Monday ordered J&amp;J to pay $16 million in compensatory damages and $950 million in punitive damages, according to court filings.
The verdict could be reduced on appeal as the U.S. Supreme Court has found that punitive damages should generally be no more than nine times compensatory damages.
Erik Haas, Johnson &amp; Johnson&#8217;s worldwide vice president of litigation, said in a statement that the company plans to immediately appeal, calling the verdict &#8220;egregious and unconstitutional.&#8221;
&#8220;The plaintiff lawyers in this Moore case based their arguments on ‘junk science’ that never should have been presented to the jury,&#8221; Haas said.
The company has said its products are safe, do not contain asbestos, and do not cause cancer. J&amp;J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product. Mesothelioma has been linked to asbestos exposure.
Trey Branham, one of the attorneys representing Moore&#8217;s family, said after the verdict that his team is “hopeful that Johnson &amp; Johnson will finally accept responsibility for these senseless deaths.”
J&amp;J is facing lawsuits from more than 67,000 plaintiffs who say they were diagnosed with cancer after using baby powder and other talc products, according to court filings. The number of lawsuits alleging talc caused mesothelioma is a small subset of these cases, with the vast majority involving ovarian cancer claims.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
J&amp;J has sought to resolve the litigation through bankruptcy, a proposal that has been rejected three times by federal courts.
Lawsuits alleging talc caused mesothelioma were not part of the last bankruptcy proposal. The company has previously settled some of those claims but has not struck a nationwide settlement, so many lawsuits over mesothelioma have proceeded to trial in state courts in recent months.
In the past year, J&amp;J has been hit with several substantial verdicts in mesothelioma cases, but Monday&#8217;s is among the largest. The company has won some of the mesothelioma trials, including last week in South Carolina, where a jury found J&amp;J not liable.
The company has been successful in reducing some of the awards on appeal, including in one Oregon case where a state judge granted J&amp;J&#8217;s motion to throw out a $260 million verdict and hold a new trial.
(Reporting by Diana Novak Jones; Editing by Alexia Garamfalvi, Rod Nickel and Bill Berkrot)

Johnson & Johnson

Johnson & Johnson Ordered To Pay Staggering Sum In Talc Cancer Case

Cancer

Courts

Health

Johnson &amp; Johnson

U.S.

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United States.
The program is designed to encourage companies to invest in domestic drug production and research by offering faster approvals for products made with U.S.-sourced ingredients and tested within the country.
Earlier this week, the FDA held a public meeting to discuss its broader efforts to support U.S. pharmaceutical manufacturing, including the PreCheck program, which aims to help set up high-priority drug facilities more quickly.
The FDA said these steps will help strengthen the U.S. drug supply chain and bring high-quality, U.S.-made generic drugs to market more quickly.
More than half of the pharmaceuticals distributed in the United States are made overseas, according to the health regulator.
As of 2025, only 9% of companies that produce the key ingredients in drugs &#8211; known as active pharmaceutical ingredients &#8211; are based in the U.S., compared to 22% in China and 44% in India, the FDA said.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
&#8220;Over-reliance on foreign drug manufacturing and testing creates risks both to national security and patient access, and undermines investments in U.S. research, manufacturing and production,&#8221; said George Tidmarsh, Director of FDA&#8217;s Center for Drug Evaluation and Research.
&#8220;It also slows down reviews and costs taxpayers more money,&#8221; he added.
The FDA also noted many important studies used to approve drugs &#8211; including tests to show that generic drugs work the same as brand-name ones &#8211; are now often done outside the U.S., which is weakening the country&#8217;s ability to lead in drug research and development.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber)

Prescription drugs

FDA Launches Pilot Program To Fast-Track Review Of Generic Drugs Made In U.S.

Prescription Drugs

Trump Administration

In a sweeping shift to align with the Trump administration’s “Make America Healthy Again” agenda, grocery giant Walmart will drop synthetic dyes and more than 30 other additives — including artificial sweeteners and preservatives — from all of its store brands.
Walmart&#8217;s brands, including Great Value, Marketside, Freshness Guaranteed, and Bettergoods, are all getting the MAHA makeover, according to the retailer. The changes will affect more than 1,000 products, including salty snacks, sweet treats, salad dressings, and power drinks.
The reformulated products are expected to hit the shelves within a matter of months, and all changes are anticipated to be fully implemented by January 2027.
&#8220;Our customers have told us that they want products made with simpler, more familiar ingredients — and we&#8217;ve listened,&#8221; Walmart U.S. CEO John Furner <a href="https://corporate.walmart.com/news/2025/10/01/walmart-u-s-moves-to-eliminate-synthetic-dyes-across-all-private-brand-food-products">said</a>. &#8220;By eliminating synthetic dyes and other ingredients, we’re reinforcing our promise to deliver affordable food that families can feel good about.”
<a class="c-link c-link--focus-visible" href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" target="_blank" rel="noopener noreferrer" data-stringify-link="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" data-sk="tooltip_parent" aria-describedby="sk-tooltip-246585">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout!</a> 
The changes are expected to have a significant impact on the American family, as Walmart plays a massive role in national grocery shopping. Just last year, the company netted $276 billion in grocery sales, for example.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who&#8217;s viewed as the figurehead of the MAHA movement, has been working with private companies to end the use of synthetic food dyes and other controversial additives. So far, major companies like PepsiCo, Tyson Foods, and Sam&#8217;s Club, among others, have signed on to the mission.
<blockquote class="twitter-tweet">
🇺🇸 MAKE AMERICA HEALTHY AGAIN!
The Trump Administration delivers on MAHA: Dozens of ice cream brands drop artificial colors, joining major companies in improving our food supply! 💪⬇️ <a href="https://t.co/NdR4u4pAya">pic.twitter.com/NdR4u4pAya</a>
— The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1945156962183749905?ref_src=twsrc%5Etfw">July 15, 2025</a></blockquote>
In addition to working with major food brands, HHS has teamed up with the Department of Agriculture to limit <a href="https://www.dailywire.com/news/why-can-food-stamps-buy-junk-food-how-doge-could-save-billions-and-maha" target="_blank" rel="noopener">food stamp</a> purchases to healthier options, generally cutting out sugary drinks and candy.
So far, at least a dozen states have had waivers authorized by Agriculture Secretary <a href="https://www.dailywire.com/news/no-amnesty-trump-usda-chief-address-deportations-of-illegal-farm-workers" target="_blank" rel="noopener">Brooke Rollins</a> to make the changes to the Supplemental Nutrition Assistance Program (SNAP).
Back in August, Kennedy reaffirmed his message that taxpayers should not be forced to pay for unhealthy foods like soda and candy, which he says are fueling the obesity epidemic in the United States and making Americans sick.
“We are spending $405 million a day on SNAP and about 10% is going to sugary drinks, and if you add candies to that, it’s about 13-17%,&#8221; he said.
“We all believe in free choice,” the secretary emphasized. “We live in a democracy — people can make their own choice about what they are going to buy and what they are not going to buy. If you want to buy a sugary soda, you should be able to do that, but the U.S. taxpayer should not pay for it.”
“U.S. taxpayers should not be paying to feed the poorest kids in the country food that will give them diabetes,” RFK added.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 BREAKING: Secretary RFK Jr. says he is officially moving to BAN food stamps from being used for soda
FINALLY!
&#8220;The U.S. Taxpayer should NOT be paying to feed the poorest kids in the country food that will give them diabetes.&#8221;
&#8220;We are spending $405 MILLION a day on SNAP..… <a href="https://t.co/jjsmZ8DrGE">pic.twitter.com/jjsmZ8DrGE</a>
— Nick Sortor (@nicksortor) <a href="https://twitter.com/nicksortor/status/1952449669163839580?ref_src=twsrc%5Etfw">August 4, 2025</a></blockquote>
Related: <a href="https://www.dailywire.com/news/more-maha-wins-12-states-cutting-soda-candy-from-food-stamps">More MAHA Wins: 12 States Cutting Soda, Candy From Food Stamps</a>

US-ECONOMY-EARNINGS-WALMART

Major MAHA Win: Walmart Cuts Dyes And Dangerous Additives From Store Brands

brooke rollins

Business

MAHA

Robert F. Kennedy Jr.

Walmart

President Donald Trump announced on Tuesday that popular medications will be offered at massively discounted prices — known as &#8220;most-favored-nation&#8221; prices — as pharmaceutical behemoth Pfizer commits to a $70 billion investment to manufacture drugs in the U.S.
<blockquote class="twitter-tweet">
President Trump: &#8220;All new medications introduced by Pfizer to the American market will be sold at the reduced, most favored nation cost.&#8221; <a href="https://t.co/S2CQxh7PKC">pic.twitter.com/S2CQxh7PKC</a>
— CSPAN (@cspan) <a href="https://twitter.com/cspan/status/1973055450980503972?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
A new website, called TrumpRX, will allow Americans to purchase drugs directly from the government rather than going through insurance. Virtually all drugs will be discounted on TrumpRX, the White House said.
Pfizer stepped up with a $70 billion investment, a shift toward making drugs in the U.S., which the Trump administration has addressed as a national security issue. 
The company is also offering all medications to Medicaid at most favored nations prices &#8212; which are prices comparable to or less than the cost of other nations&#8217; drug prices. Additionally, all new medications will be offered at most-favored-nation prices.
<a href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout</a>
Dermatitis medication, for example, will be discounted by 80% &#8212; and that refers to the net price, which is what consumers are actually paying. Meds for post-menopausal osteoporosis, which is extremely common, will be discounted by 85%. Migraine medication and rheumatoid arthritis drugs will be discounted by 50% and 40%, respectively.
<blockquote class="twitter-tweet">
PROMISES MADE, PROMISES KEPT: President Trump Delivers LOWER DRUG PRICES for Americans <a href="https://t.co/nA4tPrmcXt">pic.twitter.com/nA4tPrmcXt</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1973062430591692829?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Health officials, including Food and Drug Administration (FDA) Commissioner Dr. Marty Makary, emphasized that research and development will not stop, but instead, will no longer be funded by only American citizens while the rest of the world benefits.
Makary, for instance, called the changes the &#8220;end of the great American ripoff.&#8221; He noted that drug price offsets will be directed to developed nations like France, Germany, and the U.K.
&#8220;Today marks the end of the great American ripoff, and it also marks the beginning of the end of a great American tragedy, something I’ve seen as a physician at the bedside — patients getting spun up into a financial rage &#8230; to try to get enough money to pay for a drug &#8230; a drug that&#8217;s five or ten times more expensive than the same drug in France or Germany or the U.K.,&#8221; he said.
<blockquote class="twitter-tweet" data-media-max-width="560">
.<a href="https://twitter.com/DrMakaryFDA?ref_src=twsrc%5Etfw">@DrMakaryFDA</a>: &#8220;Today marks the the beginning of the end of the great American rip off, and it also marks the beginning of the end of a great American tragedy; something I’ve seen as a physician at the bedside — patients getting spun up into a financial rage&#8230; to try to get… <a href="https://t.co/SD0iKsZR2B">pic.twitter.com/SD0iKsZR2B</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1973063636395373048?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Dr. Mehmet Oz, who is the administrator of the Centers for Medicare &amp; Medicaid Services (CMS), echoed the sentiment, noting that the administration is &#8220;protecting medical advances for the future, while at the same time securing the drug prices Americans want, today.&#8221;
<blockquote class="twitter-tweet">
.<a href="https://twitter.com/DrOzCMS?ref_src=twsrc%5Etfw">@DrOzCMS</a>: &#8220;In July, President Trump demanded that manufacturers make a firm commitment to lower their prices “or else.” Last week, we made a major breakthrough. Protecting medical advances for the future, while at the same time securing the drug prices Americans want today.&#8221; <a href="https://t.co/56dvAt1OHi">pic.twitter.com/56dvAt1OHi</a>
— HHS.gov (@HHSGov) <a href="https://twitter.com/HHSGov/status/1973065918897881436?ref_src=twsrc%5Etfw">September 30, 2025</a></blockquote>
Trump announced his &#8220;most favored nation&#8221; pricing plans at the end of July, promising to end &#8220;global freeloading&#8221; by other developed nations. The president suggested he would use tariffs and all other &#8220;tools&#8221; available to make sure all companies provide Americans with most-favored-nation prices.
Related: <a href="https://www.dailywire.com/news/trump-signs-order-to-reduce-drug-prices-tells-rest-of-world-to-pay-up">Trump Signs Order To Reduce Drug Prices, Tells Rest Of World To Pay Up</a>

Donald Trump

‘End Of Great American Ripoff’: Trump Makes Major Drug Price Announcement

Executive

Pfizer

Politics

Drugmaker Bristol Myers Squibb is set to release a new schizophrenia treatment in the United Kingdom for the same price it’s listed for in the United States, a decision that will certainly please those in the White House who have fought to get Americans the same prices offered overseas.
The announcement, made by Bristol on Monday, follows a push from President Donald Trump for U.S. drugmakers to lower prescription drugs for Americans to the greatest extent possible. Bristol’s approach to the United Kingdom market aligns with the White House’s strategy to secure lower drug prices in the United States.
The pharmaceutical company has never before brought its price for a drug to parity across the United States and the United Kingdom. Adam Lenkowsky, chief commercialization officer at Bristol, said that the drug company is prepared to pull its drug, Cobenfy, from the European nation&#8217;s market if the relevant government authorities do not agree to the price listed in the United States, at $1,850 a month.
“Our intention is to work with NICE and NHS to make this medicine available, but we are prepared to make the difficult decision to walk away if they cannot better recognize the value our medicine brings to patients and society,” Lenkowsky said in a statement.
“We agree with the Trump Administration that other countries need to pay their fair share,” he added.
Cobenfy has not yet been approved for sale in the United Kingdom. Bristol plans to file for approval in the coming weeks and expects to receive approval sometime next year, according to the <a href="https://www.ft.com/content/0913ee5f-1631-4e1b-8bd8-99ce2c9dd64f">Financial Times</a>.
Last year, the research group RAND <a href="https://www.rand.org/news/press/2024/02/01.html">found</a> that Americans pay significantly more for prescription drugs than other countries. The research pegged the inflated price at 2.78 times what is charged in other countries.
The Trump administration is determined to end that trend, and has pointed to drug manufacturers.
“The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits,” a May 12 White House <a href="https://www.whitehouse.gov/presidential-actions/2025/05/delivering-most-favored-nation-prescription-drug-pricing-to-american-patients/">executive order</a> on drug prices says. “This egregious imbalance is orchestrated through a purposeful scheme in which drug manufacturers deeply discount their products to access foreign markets, and subsidize that decrease through enormously high prices in the United States.”
The order aims to pressure drugmakers to push for parity between prices for its drugs in the United States and elsewhere in the world. The president last week said that other countries have treated Americans unfairly when it comes to drug prices.
“For years, we&#8217;ve been paying for a pill $100 and they&#8217;re paying $10,” the president said on Fox News last week. Trump suggested he intends to pressure other countries into raising drug prices to offset the costs of making new drugs for Americans.
“The drug companies agree that I&#8217;m right, and the countries, if they don’t agree, I’ll use tariffs to get them to agree,” Trump said. “We&#8217;re going to be reducing drug costs over the next year, year and a half by not 50% or 60%, by 1,000% … You&#8217;re talking about a monumental change in health care that&#8217;s going to affect Medicare, Medicaid, even Social Security.”
<blockquote class="twitter-tweet">
.<a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@POTUS</a>: &#8220;For years, we&#8217;ve been paying sometimes for a pill, $100, and [other countries] are paying $10&#8230; We&#8217;re going to be reducing drug costs over the next year, year and a half&#8230; You&#8217;re talking about a monumental change in healthcare.&#8221; <a href="https://t.co/Pxnj8vU1hc">pic.twitter.com/Pxnj8vU1hc</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1968758480476528710?ref_src=twsrc%5Etfw">September 18, 2025</a></blockquote>

UK Hosts President Trump And First Lady Melania Trump For State Visit – Day Three

Trump Push Pays Off: Pharma Giant Says Brits Must Pay Same Price As Americans For New Drug

Big Pharma

Pharmaceuticals

United Kingdom

United States

World

On Monday, President Donald Trump and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. <a href="https://www.hhs.gov/press-room/autism-announcement-fact-sheet.html">announced findings into the concerning spike in national autism rates</a>, labeling one medication as a potential cause of autism, and another as a potential treatment.
It was announced that the use of acetaminophen during pregnancy is tied to an increased risk of autism. Acetaminophen is the active ingredient in Tylenol, one of the most widely used medications globally for pain relief and fever reduction. 
&#8220;Taking Tylenol is not good. I&#8217;ll say it. It&#8217;s not good,&#8221; Trump said, noting that it might be necessary if a pregnant woman spikes a very high fever. &#8220;There&#8217;s a lot of common sense in this.&#8221;
Trump also talked about vaccinations, saying he believes vaccines need to be spread out over a child&#8217;s life, suggesting what&#8217;s known as a &#8220;delayed schedule.&#8221; Kennedy said later in the presser that HHS is also looking at vaccinations in connection to spiked autism rates.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 BREAKING: President Trump just announced a link between TYLENOL and AUTISM — especially when taken during pregnancy
FDA is now recommending pregnant women don’t take Tylenol except in cases of extremely high fevers
Nor should Tylenol be frequently administered to young… <a href="https://t.co/odBhSl7pgZ">pic.twitter.com/odBhSl7pgZ</a>
— Nick Sortor (@nicksortor) <a href="https://twitter.com/nicksortor/status/1970230953776943321?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>
Kenvue, the maker of Tylenol, <a href="https://www.axios.com/2025/09/22/trump-tylenol-autism-announcement-kenvue">said</a> in a statement, &#8220;We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.&#8221;
Since early September, the Kenvue stock has <a href="https://economictimes.indiatimes.com/news/international/us/trump-admin-report-linking-tylenol-to-autism-sends-kenvue-stock-sliding/articleshow/124049521.cms?utm_source=chatgpt.com&amp;from=mdr">dropped</a> around 15%.
It was also revealed that the drug leucovorin, also known as folinic acid, can potentially help treat autism symptoms. A physician will need to prescribe the drug for this use.
The Daily Wire&#8217;s Morning Wire podcast host Georgia Howe spoke to FDA Commissioner Dr. Marty Makary on Monday about this announcement. He emphasized that it&#8217;s vitally important to let the public know about this potential association.
“We have an epidemic of autism that has increased 400% in the recent decades and we don&#8217;t have a known cause,&#8221; he explained. &#8220;Now this may be a cause, but when you have enough evidence to suggest an association and you have no other plausible cause, we have a duty to notify parents and doctors.”
Makary has already sent out a “Dear doctor” letter to all U.S. physicians, he said.
<blockquote class="twitter-tweet">
The Trump Administration&#8217;s Autism Action Plan <a href="https://t.co/5aY5huzg8x">pic.twitter.com/5aY5huzg8x</a>
— Rapid Response 47 (@RapidResponse47) <a href="https://twitter.com/RapidResponse47/status/1970230808968602042?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>
&#8220;We now have good data from large studies and the Harvard School of Public Health Dean has made a very conclusive statement that he believes the association is causal,&#8221; Makary explained. &#8220;So when you have that weight of evidence, you have to take it seriously and err on the side of safety, especially since the vast majority of low grade fevers do not need to be treated.”
On the issue of treating autism symptoms with leucovorin, Makary said the drug has been around for nearly a century. However, &#8220;only recently have we recognized that some kids with autism actually have an autoimmune disease,&#8221; he explained. &#8220;The mechanism may be that the body is creating antibodies that block the folate receptors on their brain, restricting the ability of folate to get into the cerebrum. And so what that does is it actually creates a situation where you could have high levels of folate in your diet.&#8221;
Back in April, Kennedy promised his findings on autism would be dropped this month. He said at the time that new data showed that autism now affects 1 in 31 children in the U.S. – that’s nearly five times higher than when the CDC started these surveys back in 1992. Even more troubling, Kennedy also said a lot of these cases are now severe. “25% of the kids diagnosed with autism are non-verbal, non-toilet trained, have other stereotypical features: head banging, tactile and light sensitivities, stimming, toe-walking, etc.,&#8221; he said.
“Secretary Kennedy is asking questions that the American people are asking,&#8221; Makary told Morning Wire. &#8220;And so we have this odd new political landscape that&#8217;s penetrated science where you&#8217;re supposedly not allowed to ask certain questions. It&#8217;s created a tremendous amount of distrust. But I can tell you the purpose of science itself is to investigate questions.&#8221;
You can watch the announcement below:
<blockquote class="twitter-tweet">
Today, President Trump and RFK Jr. announce what they describe as a historic autism breakthrough—linking prenatal medication use to increased risk and proposing a new treatment path. This unprecedented claim could reshape medicine and ignite fierce debate. <a href="https://t.co/v0fo5xyZ3w">https://t.co/v0fo5xyZ3w</a>
— Daily Wire (@realDailyWire) <a href="https://twitter.com/realDailyWire/status/1970228989890277443?ref_src=twsrc%5Etfw">September 22, 2025</a></blockquote>

Potential Cause, Treatment Of Autism Revealed By Trump, RFK Jr.

Tylenol

President Donald Trump said on Sunday that he will be making a major announcement on the autism research undertaken by Robert F. Kennedy Jr.&#8217;s Department of Health and Human Services.
&#8220;I think we&#8217;ve found an answer to autism – autism. How about that?&#8221; Trump said to tens of thousands of Americans gathered for a Charlie Kirk memorial service.
<blockquote class="twitter-tweet" data-media-max-width="560">
JUST IN &#8211; Trump says tomorrow will be the &#8220;biggest announcement medically&#8221; in the history of U.S., &#8220;I think we&#8217;ve found an answer to autism.&#8221; <a href="https://t.co/e1WrejfsfH">pic.twitter.com/e1WrejfsfH</a>
— Disclose.tv (@disclosetv) <a href="https://twitter.com/disclosetv/status/1969896398188687496?ref_src=twsrc%5Etfw">September 21, 2025</a></blockquote>
The announcement, set for Monday at 4 p.m., is expected to reveal one medication as a potential cause of autism, and another as a potential treatment.
Reports suggest Trump and Kennedy will announce that Tylenol use during early pregnancy is linked to autism. Rates of the disorder have skyrocketed in recent years, now affecting 1 in 31 children in the U.S. An August review from Mount Sinai and Harvard researchers seems to tie Tylenol to this increased risk. 
However, the CEO of Kenvue, which makes Tylenol, has denied the association and maintains that Tylenol is a safe option for pregnant women.
The administration is also expected to announce that folinic acid could help treat autism symptoms in kids. 
In April, Kennedy promised his findings on autism would be dropped this month. He said at the time that new data showed that autism now affects 1 in 31 children in the U.S. – that’s nearly five times higher than when the Centers for Disease Control and Prevention (CDC) started such surveys back in 1992. Just two years ago, the prevalence was 1 in 36 children.
Even more troubling, Kennedy also <a href="https://www.youtube.com/watch?v=yly3zpXqa2s">said</a> a lot of these cases are now severe. &#8220;25% of the kids diagnosed with autism are non-verbal, non-toilet trained, have other stereotypical features: head banging, tactile and light sensitivities, stimming, toe-walking, etc.,&#8221; the secretary explained.
<blockquote class="twitter-tweet" data-media-max-width="560">
🚨 RFK just announced the latest autism rates in 8 year old children.🚨
1 in 36 have autism.
1 in 20 boys have autism.
1 in 12.5 boys in California have autism.
California has the strictest vaccination laws in the country. Make of that what you will.
<a href="https://t.co/rHuYhqJJOG">pic.twitter.com/rHuYhqJJOG</a>
— Sara Gonzales (@SaraGonzalesTX) <a href="https://twitter.com/SaraGonzalesTX/status/1912555230245408792?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
The CEO of Kenvue, which makes Tylenol, reportedly had a “hastily scheduled meeting” with Kennedy last week over reports about the announcement. Perry argued in the private meeting that there is no causal link between Tylenol use during pregnancy and autism. He argued to Kennedy that Tylenol is a safe option for pregnant women, especially if they spike a fever, and added that other options do have links to birth defects.
Since early September, Kenvue stock has <a href="https://economictimes.indiatimes.com/news/international/us/trump-admin-report-linking-tylenol-to-autism-sends-kenvue-stock-sliding/articleshow/124049521.cms?utm_source=chatgpt.com&amp;from=mdr">dropped</a> around 15%.
When Kennedy first announced that he’d be researching the spike in autism rates, there was notable outrage from the medical establishment, legacy media, and some Democrats. They argued that Kennedy was merely pushing his “anti-vax” views and promulgating dangerous misinformation.
Even some autism organizations were unhappy. They <a href="https://autismsociety.org/statement-on-robert-f-kennedy-jr-s-comments-regarding-the-cause-of-autism-and-misleading-deadline/">condemned</a> Kennedy’s remarks, calling them “harmful, misleading, and unrealistic” and said the spike in autism cases is mostly due to better screening and diagnosis.

President Trump Participates In Swearing-In Ceremony For Medicare and Medicaid Services Administrator Dr. Mehmet Oz

‘I Think We’ve Found An Answer To Autism’: What To Know About Trump’s Major Announcement

The Advisory Committee on Immunization Practices (ACIP) — a highly influential Centers for Disease Control and Prevention (CDC) vaccine panel — held discussions and votes over the past two days on a number of vaccinations.
Specifically, the CDC panel discussed the MMRV, hepatitis B, and COVID vaccines.
On the MMRV vaccine, which protects against measles, mumps, rubella, and chickenpox, the panel voted to delay the shot until a child is at least four years old, citing an increased risk in febrile seizures. It&#8217;s still currently recommended that the MMR and chickenpox vaccine, separately, be given to young children.
The hepatitis B shot was also widely discussed, but ultimately a vote to delay the first dose, which is currently given at birth, was kicked for another time. Some advocates say the first dose is not necessary at birth if the mother herself tests negative for the disease, since hepatitis B is transmitted sexually or by blood.
The panel did vote to <a href="https://www.hhs.gov/press-room/acip-recommends-covid19-vaccination-individual-decision-making.html?utm_source=chatgpt.com">recommend</a> all pregnant women be tested for hepatitis B, a test that is covered across all insurance programs, according to Health and Human Services (HHS).
Lastly, the panel took on COVID vaccines. The panel <a href="https://thehill.com/policy/healthcare/5513336-acip-recommends-childhood-vaccine-changes/">recommended</a> that the shot &#8220;be determined by individual decision-making.&#8221; This means there is no longer a broad recommendation for all, but instead, individuals will decide after discussions with providers, including physicians, nurses, and pharmacists, according to HHS.
&#8220;It allows for immunization coverage through all payment mechanisms including entitlement programs such as the Vaccines for Children Program, Children’s Health Insurance Program, Medicaid, and Medicare, as well as insurance plans through the federal Health Insurance Marketplace,&#8221; HHS adds.
During this latest meeting, five new appointees were named to ACIP: Catherine M. Stein, Dr. Evelyn Griffin, Hilary Blackburn, Dr. Kirk Milhoan, and Dr. Raymond Pollak.
ACIP is highly influential. The panel meets a few times a year and makes recommendations to the CDC, thereby basically setting the childhood vaccine schedule and other vaccine-related recommendations, like flu shots and COVID vaccines. ACIP also heavily influences which vaccines are covered by both public and private insurance.
Back in June, HHS Secretary Robert F. Kennedy Jr. dismissed all sitting ACIP panel members over what he said were conflicts of interest. At the time, Kennedy argued in an op-ed for the Wall Street Journal that ACIP had lost the trust of the American people, effectively becoming a “rubber-stamp” for all vaccines while ignoring safety concerns and conflict of interest rules.
He said that ACIP had “never recommended against a vaccine—even those which were later withdrawn for safety reasons,” adding that the panel “failed to scrutinize vaccine products given to babies and pregnant women.”
Related: <a href="https://www.dailywire.com/news/maha-changes-are-coming-to-mcdonalds?author=Amanda+Prestigiacomo&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=MAHA+Changes+Are+Coming+To+McDonald’s">MAHA Changes Are Coming To McDonald’s</a>

Democratic Presidential Candidate Robert F. Kennedy Jr. Delivers Address To Jewish Community In New York

Vax Panel Takes On COVID, Hep B, And MMRV Vaccines. Here’s What They Decided.

COVID-19 Vaccine

Vaccines

McDonald&#8217;s USA announced this week that it&#8217;s pouring $200 million into regenerative farm practices &#8212; the largest McDonald&#8217;s investment in regenerative agriculture to date.
The move has been hailed as a win for the &#8220;Make America Healthy Again&#8221; movement, since these practices enhance soil health and make synthetic chemicals and fertilizers far less necessary.
&#8220;Thank you, [McDonald&#8217;s], for committing a record $200 million investment into regenerative agriculture. This is a big win for regenerative grazing practices, habitat restoration, water and wildlife conservation,&#8221; Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said on X.
<blockquote class="twitter-tweet">
Thank you, <a href="https://twitter.com/McDonalds?ref_src=twsrc%5Etfw">@McDonalds</a>, for committing a record $200 million investment into regenerative agriculture. This is a big win for regenerative grazing practices, habitat restoration, water and wildlife conservation. 🇺🇸 <a href="https://t.co/9f6mrFBV3Y">pic.twitter.com/9f6mrFBV3Y</a>
— Secretary Kennedy (@SecKennedy) <a href="https://twitter.com/SecKennedy/status/1968317088361271783?ref_src=twsrc%5Etfw">September 17, 2025</a></blockquote>
McDonald’s, which is the largest fast food chain in the nation, is working with the U.S. Department of Agriculture’s Natural Resources Conservation Service (NRCS) and others to invest more than $200 million over the next seven years in regenerative grazing practices, habitat restoration, and water and wildlife conservation on cattle ranches spanning 4 million acres across up to 38 states, a press release from the company outlines.
The investment, McDonald&#8217;s said, shows the company&#8217;s &#8220;continued commitment to responsible beef sourcing and stewardship of natural resources.&#8221;
Calley Means, an advisor to Kennedy, said on X, &#8220;McDonald’s invests $200 million to shift supply chain to more regenerative practices. Soil Health and regenerative practices are a true win-win between MAHA advocates and large companies. These moves should be celebrated.&#8221;
&#8220;My takeaway from a lot of engagement with food companies FWIW &#8211; this commitment to soil health is real,&#8221; Means added. &#8220;These companies depend on their soil and have a major economic interest in evolving/improving practices. Soil healthy and regenerative principles are a key theme of the MAHA report. The actions of McDonald’s are significant here and represent a roadmap about how we can drive real change.&#8221;
<blockquote class="twitter-tweet">
My takeaway from a lot of engagement with food companies FWIW &#8211; this commitment to soil health is real. These companies depend on their soil and have a major economic interest in evolving/improving practices.
Soil healthy and regenerative principles are a key theme of the MAHA…
— Calley Means (@calleymeans) <a href="https://twitter.com/calleymeans/status/1968059901391073697?ref_src=twsrc%5Etfw">September 16, 2025</a></blockquote>
HHS has already witnessed a number of major food companies voluntarily make MAHA changes, such as <a href="https://www.dailywire.com/news/another-maha-win-kraft-heinz-to-nix-all-artificial-dyes-in-two-years">dropping synthetic food dyes</a>, or <a href="https://www.dailywire.com/news/tyson-foods-will-stop-using-high-fructose-corn-syrup-by-end-of-year">halting the use of high fructose corn syrup</a>.
Related: <a href="https://www.dailywire.com/news/vax-panel-reviewing-childhood-vaccine-schedule-heres-what-theyll-vote-on?author=Amanda+Prestigiacomo&amp;category=News&amp;elementPosition=0&amp;row=0&amp;rowType=Vertical+List&amp;title=Vax+Panel+Reviewing+Childhood+Vaccine+Schedule.+Here’s+What+They’ll+Vote+On.">Vax Panel Reviewing Childhood Vaccine Schedule. Here’s What They’ll Vote On.</a>

McDonald’s Same Store Sales Up 7.1 Percent In January

MAHA Changes Are Coming To McDonald’s

Farming

Fast-Food

Food

McDonald’s

The Advisory Committee on Immunization Practices (ACIP) &#8212; a highly influential Centers for Disease Control and Prevention (CDC) vaccine panel &#8212; is meeting Thursday and Friday to discuss potential changes to the childhood vaccination schedule. 
The panel will specifically review the COVID vaccine, the hepatitis B vaccination, and the MMRV shot, which protects against measles, mumps, rubella, and chickenpox. The panel will take votes on Thursday evening and Friday afternoon regarding their recommendations for if, when, and how the three vaccines should be administered.
Regarding the COVID vaccine, there are scheduled discussions on the &#8220;genomics of vaccine-induced myocarditis,&#8221; as well as the &#8220;economic analysis of COVID-19 vaccination.&#8221; The panel is also expected to hear statements from COVID-19 vaccine manufacturers. The vote for a COVID recommendation is scheduled for 3 p.m. on Friday.
On the hepatitis B vaccine, reports this week have suggested that the panel will likely recommend that the vaccine be delayed until age four if the mother tests negative for Hep B, since the disease is transmitted sexually or by blood. Currently, the first Hep B dose is given at birth. The vote on this recommendation is scheduled for Thursday at 5 p.m.
The vote for the MMRV shot is also scheduled at 5 p.m. on Friday. Before the vote, the panel will hear a presentation on &#8220;febrile seizure&#8221; following the MMRV vaccine.
The meeting will also reportedly include the introduction of five new panel member appointees. Back in June, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. dismissed all ACIP panel members over what he said were conflicts of interest. He&#8217;s been replacing the panel with professionals he says follow gold-standard science. 
Also of note, the American Academy of Pediatrics (AAP), which controversially <a href="https://publications.aap.org/aapnews/news/25340/AAP-reaffirms-gender-affirming-care-policy?autologincheck=redirected">supports</a> trans procedures for minors, boycotted the meeting, claiming ACIP has lost credibility under Kennedy.
AAP CEO Mark Del Monte <a href="https://www.statnews.com/2025/09/18/cdc-acip-vaccine-meeting-martin-kulldorff-debate-challenge/">claimed</a> in a recent statement that ACIP “imperils children’s health.&#8221; “Rather than firing experts at ACIP and CDC and engaging in political stunts, it’s time to get back to prioritizing children’s health. That’s where our focus is. That’s where it will remain,” he added.
Related: <a href="https://www.dailywire.com/news/medical-orgs-face-pressure-over-support-for-transgender-ideology-after-deadly-shooting?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=Medical+Orgs+Face+Pressure+Over+Support+For+Transgender+Ideology+After+Deadly+Shooting">Medical Orgs Face Pressure Over Support For Transgender Ideology After Deadly Shooting</a>

CDC’s Advisory Committee On Immunization Practices Meets In Atlanta

Vax Panel Reviewing Childhood Vaccine Schedule. Here’s What They’ll Vote On.

Vax Panel Looking At Childhood Vaccine Schedule. Here’s What They’ll Vote On. 

Tyson Foods is taking another step in reshaping the food industry by pledging to eliminate controversial additives from some of America’s most well-known grocery staples. The company announced on Monday that it will stop using high fructose corn syrup, sucralose, BHA/BHT, and titanium dioxide across its U.S. branded products, including Tyson, Jimmy Dean, Hillshire Farm, Wright, State Fair, and Aidells by the end of 2025.
Earlier this year, Tyson Foods removed petroleum-based synthetic dyes from its product line. While the ingredients slated for removal are still FDA-approved and considered safe for use, Tyson says the move is about setting a higher bar for what families can expect on their dinner tables.
“We continuously review and assess our product portfolio to ensure the highest quality products that meet the needs of consumers,” <a href="https://www.tysonfoods.com/news/news-releases/2025/9/tyson-foods-plans-to-stop-using-high-fructose-corn-syrup">said</a> Donnie King, President &amp; CEO of Tyson Foods. “Our decision to remove High Fructose Corn Syrup and other ingredients reflects our ongoing commitment to feeding the world like family, while preserving the taste, value and integrity that define our iconic brands.”
The voluntary initiative builds on Tyson’s push to reduce sodium, sugars, and additives in its lineup of food products.
The announcement comes after Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced earlier this year that the Food and Drug Administration (FDA) is working with companies to phase out petroleum-based food dyes by the end of 2026 as part of the “Make America Healthy Again” agenda.
Tyson, as well as other companies including PepsiCo, vowed to make those changes ahead of schedule, as The Daily Wire previously <a href="https://www.dailywire.com/news/major-food-companies-accelerate-maha-changes-to-recipes">reported</a>.
RFK Jr. has been an outspoken critic of companies using corn syrup, calling the common sugar substitute “poison.”
High-fructose corn syrup is “just a formula for making you obese and diabetic,” Kennedy once said, according to The Wall Street Journal.
The use of high fructose corn syrup has been at the center of debate among dieticians and health experts for years, as some studies have shown a link between high-fructose corn syrup consumption and the obesity epidemic. In July, President Trump said he was speaking to Coca-Cola about using real cane sugar in their soda instead, which he said the company agreed to do.
Trump wrote on Truth Social, “This will be a very good move by them — You’ll see. It’s just better!”

Tyson Foods

Tyson Foods Will Stop Using High Fructose Corn Syrup By End Of Year

Department of Health and Human Services

General

The U.S. Food and Drug Administration (FDA) announced on Tuesday evening that it&#8217;s cracking down on deceptive pharmaceutical ads, issuing thousands of warning letters and about 100 cease-and-desist notifications.
“For far too long, the FDA has permitted misleading drug advertisements, distorting the doctor-patient relationship and creating increased demand for medications regardless of clinical appropriateness,” FDA Commissioner Dr. Marty Makary said in a statement. “Drug companies spend up to 25% of their budget on advertising. Those billions of dollars would be better spent on lowering drug prices for everyday Americans.”
A press release from the agency said current law requires pharma ads to &#8220;present a fair balance between a product’s risks and benefits; avoid exaggerating benefits; not create a misleading overall impression; properly disclose financial relationships; and include information regarding major side effects and contraindications.&#8221;
That rule, which the FDA did not adequately enforce during the Biden years, will be &#8220;aggressively&#8221; enforced now, the release says. Additionally, the FDA is closing the “adequate provision” loophole created in 1997, which companies have used to &#8220;conceal critical safety risks in broadcast and digital ads, fueling inappropriate drug use and eroding public trust.&#8221;
Television ads are not the only promotional content being scrutinized and regulated. Social media posts, which often feature an influencer talking up the drug, rarely mention &#8220;potential harms,&#8221; or they fail to disclose that the influencers are being paid.
&#8220;[W]hile 100% of pharmaceutical social media posts highlight drug benefits, only 33% mention potential harms,&#8221; the FDA said, citing a 2024 review in the Journal of Pharmaceutical Health Services Research. &#8220;Moreover, 88% of advertisements for top-selling drugs are posted by individuals and organizations that fail to adhere to the FDA fair balance guidelines.&#8221;
In the thousands of letters sent to drug companies, the FDA warns, &#8220;You are hereby directed to remove any noncompliant advertising and bring all promotional communications into compliance.&#8221;
&#8220;This notice also serves to demand compliance with the [Federal Food, Drug, and Cosmetic] Act and FDA implementing regulations and requires companies to remove any and all DTC (direct-to-consumer) prescription drug advertising that violates the law,&#8221; the letter adds.
Robert F. Kennedy Jr. &#8212; the head of Health and Human Services (HHS), which oversees the FDA &#8212; has long been a critic of Big Pharma ads. He said in a statement issued Tuesday that &#8220;pharmaceutical ads hooked this country on prescription drugs.&#8221;
&#8220;We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising,&#8221; he continued. &#8220;Only radical transparency will break the cycle of overmedicalization that drives America’s chronic disease epidemic.”
While Kennedy was running for president in 2024, before he endorsed President Donald Trump, he said he would &#8220;issue an executive order banning pharmaceutical advertising on television.&#8221;
&#8220;We are one of only two countries in the world that allow pharmaceutical companies to advertise directly to consumers on television,&#8221; RFK Jr. said on X in 2024. &#8220;Not surprisingly, Americans consume more pharmaceutical products than anyone else on the planet.&#8221;

Great American Farmers Market 2025

Trump FDA Announces Major Crackdown On ‘Misleading’ Pharma Ads

Menu